Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough Concentrations

Archive ouverte

Gautier-Veyret, Elodie | Bolcato, Léa | Roustit, Matthieu | Weiss, Stéphanie | Tonini, Julia | Brenier-Pinchart, Marie-Pierre | Cornet, Muriel | Thiebaut-Bertrand, Anne | Stanke-Labesque, Françoise

Edité par CCSD ; American Society for Microbiology -

International audience. The delayed-release tablet formulation of posaconazole (POS-tab) results in higher plasma POS trough concentrations (C min ) than the oral suspension (POS-susp), which raises the question of the utility of therapeutic drug monitoring (TDM). We aimed to compare the variability of the POS C min for the two formulations and identify determinants of the POS-tab C min and its variability.

Consulter en ligne

Suggestions

Du même auteur

Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated

Archive ouverte | Gautier-Veyret, Elodie | CCSD

International audience. Aims Cytochrome 2C19 genotype‐directed dosing of voriconazole (VRC) reduces the incidence of insufficient VRC trough concentrations ( C min ) but does not account for CYP3A polymorphisms, als...

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring

Archive ouverte | Bolcato, Léa | CCSD

International audience. Isavuconazole (ISA), a triazole antifungal agent, is licensed for the treatment of invasive aspergillosis and mucormycosis. Therapeutic drug monitoring (TDM) is a cornerstone of treatment eff...

Inflammation is a potential risk factor of voriconazole overdose in hematological patients

Archive ouverte | Gautier-Veyret, Elodie | CCSD

International audience. Abstract Voriconazole ( VRC ) overdoses are frequent and expose patients at high risk of adverse effects. This case–control study performed in hematological patients who benefited from VRC th...

Chargement des enrichissements...